A genome‐scale CRISPR knock‐out screen in chronic myeloid leukemia identifies novel drug resistance mechanisms along with intrinsic apoptosis and MAPK signaling-Reference-Cited by-同舟云学术

A genome‐scale CRISPR knock‐out screen in chronic myeloid leukemia identifies novel drug resistance mechanisms along with intrinsic apoptosis and MAPK signaling

Published:2020-07-28 Issue:18 Volume:9 Page:6739-6751
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Med

Author:

Lewis Matthieu¹^ORCID,Prouzet‐Mauléon Valérie¹,Lichou Florence¹,Richard Elodie¹,Iggo Richard¹,Turcq Béatrice¹,Mahon François‐Xavier¹

Affiliation:

1. Laboratory of Mammary and Leukemic Oncogenesis Inserm U1218 ACTION University of BordeauxBergonié Cancer Institute Bordeaux France

Funder

Ligue Contre le Cancer

Publisher

Wiley

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cam4.3231

Reference49 articles.

1. A Programmable Dual-RNA–Guided DNA Endonuclease in Adaptive Bacterial Immunity

2. Multiplex Genome Engineering Using CRISPR/Cas Systems

3. Genome-Scale CRISPR-Cas9 Knockout Screening in Human Cells

4. Genome-scale CRISPR-Cas9 knockout and transcriptional activation screening

5. Genetic Screens in Human Cells Using the CRISPR-Cas9 System

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Integrated drug profiling and CRISPR screening identify BCR::ABL1-independent vulnerabilities in chronic myeloid leukemia;Cell Reports Medicine;2024-05

2. Integrated functional genomic screening to bypass TKI resistance in chronic myeloid leukemia;Cell Reports Medicine;2024-05

3. Uncovering the bookshelves of CRISPR-based libraries: Advances and applications in cancer studies;Critical Reviews in Oncology/Hematology;2024-04

4. Compact CRISPR genetic screens enabled by improved guide RNA library cloning;Genome Biology;2024-01-19

5. CRISPR technology: A versatile tool to model, screen, and reverse drug resistance in cancer;European Journal of Cell Biology;2023-06